Robert I. Levy

Robert I. Levy's AcademicInfluence.com Rankings

Robert I. Levy

Biology

#1856

World Rank

#3009

Historical Rank

Biochemistry

#136

World Rank

#173

Historical Rank

biology Degrees

Download Badge

Biology

Robert I. Levy's Degrees

PhD Biochemistry University of Washington
Bachelors Chemistry University of California, Berkeley

Why Is Robert I. Levy Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert I. Levy's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. (1972) (31316)
The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. (1972) (1557)
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. (1967) (860)
Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study. (1984) (719)
A specific apoprotein activator for lipoprotein lipase. (1970) (607)
The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. (1972) (598)
Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. (1994) (518)
Coronary Artery Disease in 116 Kindred with Familial Type II Hyperlipoproteinemia (1974) (487)
Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. (1974) (456)
The metabolism of very low density lipoprotein proteins. II. Studies on the transfer of apoproteins between plasma lipoproteins. (1972) (439)
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. (1967) (428)
TAHITIANS: MIND AND EXPERIENCE IN THE SOCIETY ISLANDS by ROBERT I. LEVY. University of Chicago Press, 1973. 547 pp. $12.50. Reviewed by R. F. Salisbury (1975) (421)
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. (2009) (405)
The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study. (1984) (395)
High density lipoprotein metabolism in man. (1977) (385)
Studies of the proteins in human plasma very low density lipoproteins. (1969) (385)
Lipoprotein apoprotein metabolism. (1978) (353)
The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. (1983) (338)
Limitations of the electrocardiographic response to exercise in predicting coronary-artery disease. (1975) (325)
Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause. (2000) (322)
On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein. (1973) (317)
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. (1967) (308)
Lipoprotein metabolism. (1975) (265)
The biochemical, clinical, and genetic features of type III hyperlipoproteinemia. (1975) (254)
Role of Cardiovascular Risk Factors in Prevention and Treatment of Macrovascular Disease in Diabetes (1989) (240)
A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques. (1968) (236)
Comparison of the triglyceride lipase of liver, adipose tissue, and postheparin plasma. (1972) (235)
Selective measurement of two different triglyceride lipase activities in rat postheparin plasma. (1973) (234)
Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects. (1978) (222)
The effects of low cholesterol, high polyunsaturated fat, and low fat diets on plasma lipid and lipoprotein cholesterol levels in normal and hypercholesterolemic subjects. (1981) (207)
Lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease. (1969) (205)
Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood. (1974) (196)
PLASMA-TRIGLYCERIDES IN REGULATION OF H.D.L.-CHOLESTEROL LEVELS (1978) (189)
Acute muscular syndrome associated with administration of clofibrate. (1968) (186)
Dietary and drug treatment of primary hyperlipoproteinemia. (1972) (186)
Pathogenesis and management of lipoprotein disorders. (1985) (186)
Type III hyperlipoproteinemia: an analysis of two contemporary definitions. (1975) (174)
Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. (1978) (173)
Biosynthesis of lymph and plasma lipoprotein apoproteins by isolated perfused rat liver and intestine. (1973) (172)
Further Observations on the Activation and Inhibition of Lipoprotein Lipase by Apolipoproteins (1973) (171)
The nature of pre beta (very low density) lipoproteins. (1966) (169)
Further characterization of apolipoproteins from the human plasma very low density lipoproteins. (1970) (163)
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. (1967) (160)
Cholesterol, lipoproteins, apoproteins, and heart disease: present status and future prospects. (1981) (160)
HETEROGENEITY OF PLASMA HIGH DENSITY LIPOPROTEINS. (1965) (159)
Adenine phosphoribosyltransferase deficiency: a previously undescribed genetic defect in man. (1968) (153)
Neonatal diagnosis of familial type-II hyperlipoproteinaemia. (1973) (151)
Nutrition, Lipids and Coronary Heart Disease (1979) (150)
Discontinuous respiration in insects. II. The direct measurement and significance of changes in tracheal gas composition during the respiratory cycle of silkworm pupae. (1966) (142)
Total Inhibition of Hepatic β-Lipoprotein Production in the Rat by Orotic Acid (1967) (135)
Metabolic fate of rat and human lipoprotein apoproteins in the rat. (1973) (133)
Effects of hyperlipoproteinemias and their treatment on the peripheral circulation. (1970) (132)
Fractionation of the C-apoproteins from human plasma very low density lipoproteins. (1973) (130)
Mesocosm: Hinduism and the Organization of a Traditional Newar City in Nepal (1992) (124)
On the protein defect in abetalipoproteinemia. (1971) (121)
Declining mortality in coronary heart disease. (1981) (117)
Characterization, subcellular localization, and partial purification of a heparin-released triglyceride lipase from rat liver. (1973) (114)
Electron microscopic study on reassembly of plasma high density apoprotein with various lipids. (1971) (105)
Diagnosis and management of hyperlipoproteinemia. (1968) (105)
Cardiovascular research: decades of progress, a decade of promise. (1982) (103)
Cardiovascular pathology in hyperlipoproteinemia. Anatomic observations in 42 necropsy patients with normal or abnormal serum lipoprotein patterns. (1973) (103)
Further separation of the apoproteins of the human plasma very low density lipoproteins. (1970) (103)
Studies on the protein defect in Tangier disease. Isolation and characterization of an abnormal high density lipoprotein. (1972) (89)
Production of β-Lipoprotein by Intestine in the Rat (1968) (85)
Quantitative agarose gel electrophoresis of plasma lipoproteins: a simple technique and two methods for standardization. (1973) (84)
Evidence for separate monoglyceride hydrolase and triglyceride lipase in post-heparin human plasma. (1969) (84)
Further characterization of the apolipoproteins of rat plasma lipoproteins. (1970) (80)
Treatment of hyperlipidemia. (1974) (78)
On the lipoprotein abnormality in type III hyperlipoproteinemia (1971) (75)
Effects of orotic acid on purine and lipoprotein metabolism in man. (1970) (71)
Discontinuous respiration in insects. IV. Changes in intratracheal pressure during the respiratory cycle of silkworm pupae. (1966) (70)
A Quarter Century of Drug Treatment of Dyslipoproteinemia, With a Focus on the New HMG‐CoA Reductase Inhibitor Fluvastatin (1993) (69)
The lipoproteins and lipid transport in abetalipoproteinemia. (1966) (68)
Dietary management of hyperlipoproteinemia. (1971) (67)
Identity of Very Low Density Lipoprotein Apoproteins of Plasma and Liver Golgi Apparatus (1970) (67)
Coronary Calcifications in the Detection of Coronary Artery Disease and Comparison with Electrocardiographic Exercise Testing (1979) (66)
Hypolipidemic drugs and lipoprotein metabolism. (1972) (65)
Changes in high-density lipoprotein protein composition after heparin-induced lipolysis. (1971) (65)
A further characterization of lipoprotein lipase. (1968) (63)
The use of polyacrylamide gel electrophoresis in differentiating type 3 hyperlipoproteinemia. (1973) (60)
On the apoprotein composition of human plasma very low density lipoprotein subfractions. (1972) (58)
Percutaneous transluminal coronary angioplasty-a status report. (1981) (56)
The structure and metabolism of chylomicrons and very low density lipoproteins (VLDL). (1971) (55)
AMELIORATION OF HYPERTRIGLYCERIDÆMIA BY PROGESTATIONAL DRUGS IN FAMILIAL TYPE-V HYPERLIPOPROTEINÆMIA (1969) (54)
Hyperlipoproteinemia. A review of the five types with first report of necropsy findings in type 3. (1970) (54)
Structural and compositional changes attending the ultracentrifugation of very low density lipoproteins. (1975) (51)
Percutaneous transluminal coronary angioplasty. (1979) (51)
Acute tendinitis and arthritis. A presenting symptom of familial type II hyperlipoproteinemia. (1968) (51)
Homozygous Familial Hypercholesterolemia (1975) (50)
Introduction: Self and Emotion (1983) (49)
Studies on mercurial diureis: renal excretion, acid stability and structure-activity relationships of organic mercurials. (1962) (48)
Current therapy for hypercholesterolemia. (1989) (48)
Characterization of lipoprotein in a kindred with familial hypercholesterolemia. (1982) (48)
The decline in cardiovascular disease mortality. (1981) (48)
Causes of the decrease in cardiovascular mortality. (1984) (47)
Diagnosis and management of hyperlipoproteinemia in infants and children. (1973) (46)
Primary type V hyperlipoproteinemia. A descriptive study in 32 families. (1977) (45)
On the nature of circulating lipoproteins of intestinal origin in the rat. (1970) (45)
Reliability of assessing change with sequential coronary angiography. (1982) (45)
Hyperlipidemia : diagnosis and therapy (1977) (44)
Discontinuous respiration in insects. 3. The effect of temperature and ambient oxygen tension on the gaseous composition of the tracheal system of silkworm pupae. (1966) (43)
National Heart, Lung, and Blood Institute type II Coronary Intervention Study: design, methods, and baseline characteristics. (1982) (43)
Pseudohomozygous type II hyperlipoproteinemia. (1974) (39)
Cardiovascular pathology in hyperlipoproteinemia (HLP) (1973) (38)
The current status of hypolipidemic drugs. (1970) (37)
Correction of COOH-terminal amino acids of human plasma very low density apolipoproteins. (1971) (37)
Positional specificity of triglyceride lipases in post-heparin plasma. (1973) (36)
Stroke decline: implications and prospects. (1979) (36)
Effects of factors predisposing to atherosclerosis on formation of coronary collateral vessels. (1974) (35)
The Efficacy of Clofibrate (CPIB) in Familial Hyperlipoproteinemias (1969) (34)
Observations on the conformation of human beta lipoprotein: evidence for the occurrence of beta structure. (1968) (33)
Cholesterol and cardiovascular disease: no longer whether, but rather when, in whom, and how? (1985) (33)
The kinetic properties of very low density lipoprotein triglyceride in type 3 hyperlipoproteinemia. (1973) (30)
The structure and properties of human beta-lipoprotein and beta-apoprotein. (1968) (29)
An Experimental Solution to the Paradox of Discontinuous Respiration in Insects (1958) (29)
ETHACRYNIC ACID IN ACUTE PULMONARY EDEMA. (1965) (29)
Cutaneous cholesterol ester deposition in Tangier disease. (1967) (28)
Hydrolysis of diglyceride and glyceryl monoester diethers with "lipoprotein lipase". (1970) (27)
Status Epilepticus: Mechanisms of Brain Damage and Treatment (1984) (27)
Progression of coronary atherosclerosis in patients with probable familial hypercholesterolemia. Quantitative arteriographic assessment of patients in NHLBI type II study. (1989) (27)
Solid phase radioimmunoassay of apolipoprotein B (apo B) in normal human plasma. (1976) (26)
THE COMMUNITY FUNCTION OF TAHITIAN MALE TRANSVESTITISM: A HYPOTHESIS' (1971) (26)
Role of dietary intervention in the primary prevention of coronary heart disease. Individuals with high-normal or elevated serum cholesterol levels should be placed on cholesterol-lowering diets. (1987) (26)
Ana Pauker: The Rise and Fall of a Jewish Communist (2001) (25)
Human serum beta-lipoprotein: preparation and properties of a delipidated, soluble derivative. (1968) (25)
Degradation products from human serum high density lipoproteins following dehydration by rotary evaporation and solubilization. (1972) (24)
The composition and metabolism of high density lipoprotein subfractions (1979) (24)
The effects of acid-base balance on the diuresis produced by organic and inorganic mercurials. (1958) (23)
Effects of clofibrate (Atromid S) on the thyroxine-binding capacity of thyroxine-binding globulin and free thyroxine. (1969) (22)
A comparaive study of the effects of chemical modification on the immunochemical and optical properties of human plasma low-density lipoprotein(s) and apoproteins. (1973) (22)
Hyperlipoproteinemia and coronary heart disease. (1972) (22)
The psychodynamic functions of alcohol. (1958) (21)
The Composition, Structure, and Metabolism of High Density Lipoprotein (1976) (20)
Therapeutic failure in familial type II hyperlipoproteinemia. (1976) (20)
Primary prevention of coronary heart disease by lowering lipids: results and implications. (1985) (18)
The Typing of Hyperlipoproteinemia: A Progress Report (1968) (1969) (18)
DECISION‐MAKING IN PLANNING LARGE‐SCALE COMPARATIVE STUDIES (1978) (17)
The effect of hypolipidemic drugs on plasma lipoproteins. (1977) (17)
Position on percutaneous transluminal coronary angioplasty (PTCA) (1979) (16)
Chylomicrons and the formation of foam cells in type I hyperlipoproteinemia. A morphologic study. (1973) (16)
METHODOLOGY IN THE ANTHROPOLOGICAL STUDY OF EMOTION (1989) (15)
Cholesterol and disease--what are the facts? (1982) (15)
Dietary Prevention of Coronary Artery Disease—A Policy Overview (1980) (14)
Changing perspectives in the prevention of coronary artery disease. (1986) (14)
On the nature and functions of the emotions: An anthropological perspective (1982) (14)
Cholesterol and coronary artery disease. What do clinicians do now? (1986) (14)
Nutrition in health and disease, Vol. 1. Nutrition, lipids, and coronary heart disease. A global view. (1979) (13)
Intravenous fructose treatment of acute alcohol intoxication. Effects on alcohol metabolism. (1977) (13)
Primordial prevention of cardiovascular disease risk factors: panel summary. (1999) (13)
Progress toward prevention of cardiovascular disease. A 30-year retrospective. (1979) (12)
Resting levels of blood fibrinolysis in hyperlipoproteinemia. (1974) (12)
Mead, Freeman, and Samoa: The Problem of Seeing Things as They Are (1984) (12)
Progress in prevention of cardiovascular disease. (1978) (12)
A Conjunctive Pattern in Middle Class Informal and Formal Education (1975) (12)
Secondary prevention and lipid lowering: results and implications. (1985) (11)
Partial delipidation of human serum β-lipoprotein by sodium decyl sulfate (1969) (11)
Drug therapy of hyperlipoproteinemia. (1976) (11)
Current status of the cholesterol controversy. (1983) (11)
Letter: Portacaval shunt in familial hypercholesterolaemia. (1974) (11)
Lipid, glucose, and insulin interrelationships in normal, prediabetic, and chemical diabetic subjects. (1976) (10)
Composition and metabolism of high-density lipoproteins. (1979) (10)
Mechanisms involved in hyperlipidemia. (1969) (9)
Human Serum Beta-Lipoprotein (1968) (9)
High density lipoproteins, 1978—An overview (1978) (9)
Selective Inhibition of Hepatic but Not Intestinal β-Lipoprotein Production and Triglyceride Transport in Rats Given Orotic Acid (1969) (9)
The Framingham Study: The Epidemiology of Atherosclerotic Disease (1981) (9)
Report on the Lipid Research Clinic trials. (1987) (8)
Total inhibition of hepatic beta-lipoprotein production in the rat by orotic acid. (1967) (8)
The short-term effect of cortisone acetate upon fasting triglyceride and cholesterol in normal subjects and offspring of diabetic couples. (1972) (7)
GREGORY BATESON 1904‐1980 (1982) (7)
Preventing the preventable. (1980) (7)
Familial type III hyperlipoproteinemia. (1977) (7)
The Structure, Function and Metabolism of High‐density Lipoproteins: A Status Report (1980) (7)
Overwhelming salicylate intoxication in an adult. Acid-base changes during recovery with hemodialysis. (1967) (6)
HYPOLIPIDEMIC DRUGS AND HYPERLIPOPROTEINEMIA (1971) (6)
Type III -Hyperlipoproteinemia (1976) (6)
A Functional View of the Plasma Lipoproteins (1966) (6)
Selective Measurement of Lipoprotein Lipase and Hepatic Lipase in Post-Heparin Plasma (1974) (6)
Nutritional Prevention of Cardiovascular Disease (1985) (6)
Current status of the role of dietary treatment in the prevention and management of coronary heart disease. (1979) (6)
Ethnography, Comparison, and Changing Times (2005) (6)
Production of beta-lipoprotein by intestine in the rat. (1968) (6)
31 – THE METABOLISM OF PLASMA LIPOPROTEINS (1970) (6)
Treatment of essential hyperlipidaemia. (1970) (6)
The hyperlipidemias and coronary artery disease. (1972) (5)
Homozygous familial hypercholesterolemia. A possible biochemical explanation of clinical heterogeneity. (1975) (5)
LARGE‐SCALE CLINICAL TRIALS: ARE THEY WORTH THE COST? (1982) (5)
Lipid Lowering Drugs and Hyperlipidaemia (2012) (5)
The “Right Deviation” of Ana Pauker (1995) (5)
Estimation oftheConcentration of Low-Density Lipoprotein Cholesterol inPlasma, Without UseofthePreparative Ultracentrifuge (1972) (5)
Dissimilation of glucose-1-phosphate and of fructose-1, 6-phosphate by isolated rat diaphragm and by cell-free effluent from rat diaphragm. (1953) (5)
Discussion—the decrease in coronary heart disease mortality (1984) (4)
Consideration of cholesterol an noncardiovascular mortality (1982) (4)
Pathways of lipoprotein metabolism: integration of structure, function and metabolism. (1975) (4)
Testing the lipid hypothesis. Clinical trials. (1978) (4)
Consideration of cholesterol and noncardiovascular mortality. (1982) (4)
Teaching of the Tahitian language in the schools of French Polynesia (1970) (4)
Currently available lipid-lowering agents. (1988) (4)
NHLBI position on percutaneous transluminal coronary angioplasty (PTCA) (1979) (4)
The lipoprotein apoproteins. Their role in normal lipid transport and dyslipoproteinemia. (1974) (3)
The power of space in a traditional Hindu city (1997) (3)
Local rationality, ideal rationality and emotion (1985) (3)
Studies in a patient with chyluria. Relationship of dietary lipid to urinary fat excretion. (1966) (3)
On the mechanism of action of alpha-tocopheryl phosphate, with special reference to carbohydrate metabolism of striated muscle. III. Inhibition of insulin-induced glycogenesis in isolated rat diaphragm. (1953) (3)
Ana pauker and the mass emigration of Romanian Jewry, 1950-1952 (1998) (3)
Clinical Experience with Fluvastatin, the First Synthetic HMG-CoA Reductase Inhibitor (1993) (3)
Studies of the Protein Defect in Tangier Disease (1970) (3)
Classification and etiology of hyperlipoproteinemias. (1971) (3)
Does hypolipidemic therapy prevent coronary heart disease? (1974) (3)
New directions in psychological anthropology: A prologue to a psychiatric anthropology (1993) (3)
Hyperlipoproteinemia. Some basic concepts on diagnosis and management. (1973) (2)
Cardiovascular Pathology in Hyperlipoproteinemia (HLP). (1973) (2)
Intervention on Single Risk Factors: Hyperlipoproteinemia (1983) (2)
On the Lipoprotein Abnormality in Type III (2)
The Meaning of Lipid Profiles. (1975) (2)
No muscle damage from clofibrate. (1969) (2)
The plasma lipoproteins: an overview. (1976) (2)
On the mechanism of action of alpha-tocopheryl phosphate, with special reference to carbohydrate metabolism of striated muscle. II. Effect on the capacity of rat diaphragm to dissimilate hexose phosphates. (1953) (2)
On thelipoprotein abnormality in type 3 hyperlipoproteinemia. (1971) (1)
Workshop: Plasma Lipoproteins (1974) (1)
Coronary Artery Disease Risk in Familial Type II Hyperlipoproteinemia (1974) (1)
Horror and Tragedy: The Wings and Center of the Moral Stage (1985) (1)
Hyperlipoproteinemia: concepts of diagnosis and menagement. (1976) (1)
Interconversions of Apolipoprotein Fragments (1975) (1)
Report of the National Heart and Lung Institute Panel on Hyperlipidemia and Premature Atherosclerosis (1970) (1)
Progress toward prevention of cardiovascular disease: a thirty-year retrospective. (1978) (1)
Book Review: Review of Tismaneanu’s Stalinism for All Seasons: A Political History of Romanian Communism (2004) (1)
Lipolytic Activities of Hepatic Plasma Membrane Origin in Postheparin Plasma (1974) (1)
Preparation and properties of an apoprotein derivative of human serum beta-lipoprotein. (1968) (1)
Physiological rationale for differential drug therapy. (1975) (1)
KENNETH LAINE KETNER, ED., PEIRCE AND CONTEMPORARY THOUGHT: PHILOSOPHICAL INQUIRIES (1996) (1)
What are the Comparative Risks versus Benefits for Bile Acid Sequestrants, HMG Co-A Reductase Inhibitors, Nicotinic Acid, Probucol, and Fibric Acid Derivatives? (1989) (1)
Therapy for hypercholesterolemia; standardization of cholesterol measurements. (1990) (1)
Personal forms and meanings in Tahitian protestantism (1969) (1)
Rational drug therapy of the hyperlipoproteinemias, Part I. (1986) (0)
Introduction (1980) (0)
Current initiatives of the National Heart and Lung Institute in cardiovascular disease. (1976) (0)
Review: History of Nephrology 4: Reports from the Third Congress of the International Association for the History of Nephrology (2004) (0)
The physician and prevention. (1981) (0)
Studies ontheProtein Defect inTangier Disease (1972) (0)
The diagnosis and treatment of lipid transport disorders. (1969) (0)
Rational drug therapy of the hyperlipoproteinemias, Part II. (1986) (0)
Social/Cultural Anthropology: Oceania: The Native Cultures of Australia and the Pacific Islands. Douglas L. Oliver. Vols. 1 and 2 (1990) (0)
An expanded challenge for preventive dentistry. (1978) (0)
Cultural/Ethnology: Nepal Mandala: A Cultural Study of the Kathmandu Valley, Vols. 1 and 2 (1985) (0)
The diagnosis and treatment of lipid transport disorders. (1969) (0)
A New Era of Lipid-Lowering Drug Alternative: Workshop in Laguna Niguel, Calif., October 1988 (1989) (0)
Prognosis of the hyperlipoproteinemias. (1975) (0)
Turnover of plasma lipoproteins. (1972) (0)
Diagnosis and treatment of lipid transport disorders. (1969) (0)
Diagnosis and treatment of lipid transport disorders. (1969) (0)
The serum sodium concentration: facts and fancy. (1962) (0)
HYPOLIPIDEMIC DRUGS ON PLASMA LIPOPROTEINS (1977) (0)
History of Nephrology 4: Reports from the Third Congress of the International Association for the History of Nephrology (review) (2004) (0)
Diagnosis and treatment of lipid transport disorders. (1969) (0)
Primary Type V Hyperlipoproteinemia (2020) (0)
Two Tahitian Villages: A Study in Comparisons. (1984) (0)
Transnistria, 1941–1942: The Romanian Mass Murder Campaigns (review) (2008) (0)
Chapter 8 Hyperlipidemia and Vascular Disease (1976) (0)
Pathophysiology of lipid transport disorders. (1975) (0)
Did Ana Pauker Prevent a “Rajk Trial” in Romania? (1994) (0)
Hypercholesterolemia: genetic, dietary, and pharmacologic interrelationships. (1981) (0)
Aneurism of the Aorta (1907) (0)
FEDERAL INTERESTS AND POLICIES RELATED TO ARTIFICIAL INTERNAL ORGAN DEVELOPMENT. (1977) (0)
GENERAL AND ETHNOLOGY: Changing Perspectives in Mental Illness. Stanley C. Plog and Robert B. Edgerton, eds (1970) (0)
Hyperlipidemia and Vascular Disease (1976) (0)
Book Reviews/Comptes Rendus: The History of Albuminous Nephritis by Pierre-François Olive Rayer (2007) (0)
Fredrickson D S, Levy R I an integrated approach to mechanisms and disorders. N. Engl. J. Med. 276:34-44, 94-103, 148-56, 215-25, 273-81; 1967 (2004) (0)
[Verification of the lipid hypothesis by drug intervention]. (1985) (0)
ANTIBIOTIC AND DIGITALIS ADMINISTRATION IN UREMIA. (1964) (0)
Origin and fate of lipoproteins. (1973) (0)
Books Received (1974) (0)
Dietary Management of Hyperlipoproteinemia1 (1971) (0)
A Previously Undescribed Genetic Defect inMan (1968) (0)
The analyst’s desire between singularity of the act and “a few others” 1 (2018) (0)
AN OVERVIEW OF THE CARDIOVASCULAR DISEASE RISK FACTORS OF DIETARY ORIGIN (1986) (0)
Beta lipoprotein protein turnover: an approach to the understanding of drug and disease mechanisms. (1972) (0)
CORONARY ARTERY DISEASE The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease : results of the NHLBI pe II Coronary Intervention Study (2005) (0)
Deliberative Referendums in Deeply Divided Societies (2020) (0)
Testing the Relationship between Cholesterol Lowering and Cardiovascular Disease---Past, Present, and Prospects (1990) (0)
Effects of Chenodeoxycholic Acid (CD) Treatment on Endogenous Plasma Triglyceride (TG) Transport in Hyperlipoproteinemia (HLP) (1978) (0)
The mechanisms of action of lipid-lowering drugs (1991) (0)
Lipoproteins and atherosclerosis (1988) (0)
DECLINING MORTALITY IN CORONARY HEART DISEASE Levy (2005) (0)
Reviewers of Manuscripts and Books (1970) (0)
Replies to Ueshima, Iida, and Komachi (1979) (0)
Psychogenic musculoskeletal reactions. (1955) (0)
Diagnosis and treatment of lipid transport disorders. (1969) (0)
Interconversions of apolipoproteins fragments. (1975) (0)
Pathophysiology of lipid transport disorders. (1975) (0)
Selected Papers on Lipoproteins and Atherosclerosis (1970) (0)
New tools for treating heart disease. (1981) (0)
Steroid blocking agents as diuretic agents. (1961) (0)
CHILD MANAGEMENT STRUCTURE (2016) (0)
Partial delipidation of human serum beta-lipoprotein by sodium decyl sulfate. (1969) (0)
Differential drug therapy of the hyperlipoproteinaemias. Physiological rationale for differential drug therapy. (1975) (0)
Some clinical implications of the results of the Lipid Research Clinics Program Prevalence Study. (1986) (0)
A Theoretical Perspective (2018) (0)
NHLBI supports diverse research. (1979) (0)
Preparation and properties of an apoprotein derivative of human serum β-lipoprotein (1968) (0)
Olly-olly in come free. (1984) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert I. Levy?

Robert I. Levy is affiliated with the following schools:

Columbia University